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Abstract
Among the intangible assets, intellectual capital is the 
crucial capital for business performance and product 
development in companies. The purpose of this study is 
to determine to what extent, new product development 
influence by intellectual capital (IC) in Isfahan 
pharmaceutical firms. IC is a concept that comprises 
of three elements: human capital, structural capital and 
customer capital. Sample population of this study is 
among the product managers, research and development 
and laboratory employees of pharmaceutical firms of 
Isfahan that comprises of 91 persons sample populations. 
Method used in this study is survey-descriptive and for 
data collecting, Bontis standard questionnaire was used. 
Then data analyzed with PLS software (Next generation 
of Structural Equation Modeling). Finding shows that 
structural capital of Isfahan pharmaceutical firms has 
the most effect on new product development. Human 
capital has the most effect on structural capital. Human 
capital doesn’t have the meaningful effect on new product 
development. This study suggests the managers of these 
firms to reinforce innovative behavior of their employees. 
R2 statistic of whole model shows that generally new 
product development derives from IC about 34.8% in 
pharmaceutical firms of Isfahan.
Key words: Intellectual capital; New product 
development; Partial least square method
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Despite the role of intellectual capital as a source of 
competitive advantage, its significance has not been yet 
fully appreciated by most companies and organizations 
(Collis, 1996). An increased awareness among corporate 
managers and industry leaders regarding significance 
of intellectual capital and building new capacities for 
promotion of intellectual capital within organizations the 
key to superior performance and continuous improvement 
of product and process in the respective industry. 
Pharmaceuticals, an industry primarily dealing with health 
issues and saving lives, requires intensive knowledge 
work on a continuous basis in order to meet diverse 
consumer needs. Researchers maintain that the industry 
is especially characterized by its heavy dependence on 
intellectual capital for capital renewal (Zucker, Darby, 
& Brewer, 1994). It is a highly knowledge-intensive 
operation because producing drug from raw substances 
requires much knowledge and extensive R&D activities. 
According to Hsu and Fang (2009), and Chen, James 
Lin and Chang (2006), among the intangible assets, 
intellectual capital is the most crucial one for business 
performance and product development in companies.
This paper investigates the effect of intellectual 
capitals (i.e. human capital, structural capital, and 
customer capital) on development of new product in 
pharmaceuticals companies of Isfahan province. In 
particular, this study explains the degree to which the 
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dependent variable new product development is influenced 
by the independent variable intellectual capitals in the 
mentioned firms. However, special emphasis is placed 
on human resources in these companies. According to De 
Jong and Hertzog (2007), one way to increase innovation 
in organizations is investment on their employees. Chen, 
et al. (2006) classify critical success factors (CSFs) in 
new product development as human capital, structural 
capital and relational capital. Studies by Griffin (1997) 
indicate 32.4 percent of corporate sales were realized from 
development of new products.
Visiting the rare diseases treatment centers, such as 
cancer and MS, in Isfahan, would leave no doubt about 
the urgent need of the patients for the medications which 
for the most part are procured from foreign sources, and 
the rise in their price or their unavailability every now 
and then have been giving the patients a really hard time. 
At this time, pharmaceutical companies are expected 
by relying on intellectual capacity of their specialized 
workforce and domestic resources, as well as profiting 
from the latest technology to successfully carry out the 
momentous mission of independence from foreign sources 
for production of strategic and critical pharmaceutical 
products, while satisfying the patients’ needs by providing 
them with internationally competitive, quality drugs. 
Human resource experts and scholars almost univocally 
point to intellectual capital as the key factor which 
significantly contribute to development and prosperity of 
nations and businesses (Bounfour & Edvinsson, 2005; Lin 
& Edvinsson, 2011; Chou & Bontis, 2002).
1.  RESEARCH BASIC CONCEPTS AND 
BACKGROUND
The notion of intellectual capital in 1990 made its 
entry into the business as a brand new concept, and 
within a decade, from a quite novel idea turns into a 
well established and frequently used term in business 
lexicon. Human resource mangers view intellectual 
capital as the sum of employee’s skills, knowledge, 
and aptitude. Marketing managers think of intellectual 
capital in terms of commercial concepts involving such 
instances as recognition of trade mark and customer 
satisfaction crucial to business success, whereas in view 
of IT managers, intangible key assets are identified as 
software applications and network capabilities (Marr, 
2005). Intellectual capital, in fact, is a multidimensional 
concept made up of human, structural, and customer 
capital (Stewart, 1997). Human capital includes all the 
economically valuable assets imbedded in employees 
of an organization but the organization is not an owner 
thereof and remains at disposal of the employee (Hsu & 
Fang, 2009). Structural capital is the knowledge which 
remains in organization outside the employee’s working 
hours when they leave for home (Ordonez de Pablo’s, 
2009). Customer capital refers to the value created for 
the organization through relationship with stockholders, 
customers, and suppliers (Hsu & Fang, 2009). Studies 
conducted in regard to intellectual capital and its effect on 
the firm performance (both in public and private sector) 
suggest an association between intellectual capital and 
high profitability and performance in these firms. Study 
by Ahmad Sharabati, NajiJawad, and Bontis (2010) on 
the effect of intellectual capital determinants on business 
performance in Jordanian pharmaceutical companies 
report strong and significant role of these determinants 
in business performance of these companies. In study of 
the relationship between intellectual capital efficiency 
and market value of Iranian pharmaceutical companies 
by Mehralian, et al. (2012), such effect was not found. 
In addition, Rostami, et al. (2010) examined the effect 
of intellectual capital on financial performance in the 
Iranian pharmaceutical industry and concluded that there 
was no evidence based on which the changes in market 
value of the companies could be ascribed to performance 
of intellectual capital and it seemed that the Iranian 
pharmaceutical market to be still more sensitive to 
tangible capitals rather than to intellectual capitals.
1.1  New Product Development
CSFs of new product development are the largely explored 
managerial topics which due to their mostly applied 
aspects have inspired a multitude of research works all 
around the globe. As a result, a large variety of factors and 
conditions have been introduced as CSF sin new product 
development. In one approach, CSFs of new product 
development are outlined in 5 general categories: (1) New 
product development should be aligned with customer 
wishes; (2) The firm should adequately define its target 
market, its position in that market and its market value, as 
well as the product concept, functions and features before 
embarking on new product development; (3) Managers 
should actively pursue employee empowerment, allowing 
them to apply new ideas and to establish interdepartmental 
collaboration in development of new product; (4) The 
company should have gathered sufficient in-house 
potentials for innovations; and (5) Highly motivated 
employees strongly committed to quality control and 
business performance. In addition, a lofty innovative 
culture has been shown to be positively related to new 
product development operation (Chen, James, & Chang, 
2006). CSFs of new product development, in view of 
researchers, can be brought under three generic types of 
capitals, namely human capitals, structural capitals, and 
customer capital (Cooper & Kleinschmidt, 1996).
1.2  The Conceptual model
Based on the findings of Hsu and Fang (2009), Alegre 
and Chiva (2009) on intellectual capital and new product 
development, and review of the literature, the following 
conceptual model’s constructed (Figure 1), which displays 
contribution of intellectual capitals to the process of new 
product development.
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1.3   Research Hypotheses
(1) Human capital has a positive and significant effect on 
structural capital in pharmaceutical companies.
(2) Human capital has a positive and significant effect 
on customer in pharmaceutical companies.
(3) Human capital has a positive and significant effect 
on new product development in pharmaceutical companies.
(4) Structural capital has a positive and significant effect 
on new product development in pharmaceutical companies.
(5) Customer capital has a positive and significant effect 
on new product development in pharmaceutical companies.
2.  mETHODOLOGY
This is an applied research which is conducted based on 
a descriptive survey design. Further, in present work, 
human capital is measured as a formative construct, 
while the other two elements of intellectual capital 
(i.e. structural capital and customer capital), and new 
product development are held as reflective constructs. 
The information gathering tool is a questionnaire derived 
from Standard Questionnaire Intellectual Capital Bontis 
(1998) which is a widely applied index for an inventory 
of intellectual capital in organizations and enterprises 
(Bontis, 1998; Bontis, et al., 2000; Angstrom, et al., 
2003; Hsu & Fang, 2009; Ahmad Sharabati, et al., 2010). 
To evaluate the three elements of intellectual capitals, 
20 questions were selected, and for assessment of the 
criterion variable, new product development, 5 other 
questions were composed based on the literature of 
new product development. The respondent answer to 
the items in this questionnaire was measured in Likert 
5-point scale, ranging from 1 = fully disagree to 5 = fully 
agree. According to our inquiry from the Internet site of 
the Iranian Ministry of Industries and Mines, in total 16 
pharmaceutical companies were registered in Isfahan 
province, of this number, 6 units were reported as active 
all of which were included in the study and received the 
questionnaire. In general, the most complex regression 
model occurs in two instances: the one concerns 
dimensions of the most complex construct and the other is 
the regression model for the largest number of constructs 
whose path towards the construct is endogenous. The 
required sample size in partial least square (PLS) model is 
at least 10 times the number of predictor variables in either 
of the above two cases (of which the greater one will be 
taken into account) (Martinez-Torres, 2006). In our study, 
there are 3 constructs whose path towards the construct is 
endogenous (these being structural, customer, and human 
capitals), and there are 7 indicators of the formative 
construct (i.e. human capital). Given the greater number of 
the latter one, the sample size is set 10 times the number 
of these indicators, which implies a minimum required 
sample size of 70 respondents. After explaining the nature 
of our study to managing director of the companies and 
letting them know that participation of active people in 
new product development and marketing is needed, 91 
employees in total were selected as the respondents of 
whom 80 people answered the questionnaire and returned 
it. Having checked the received questionnaires, 72 of 
them were regarded usable which indicated a satisfactory 
response rate of 79.1 percent.
Test of hypotheses and model analysis was performed 
using partial least square (PLS) method.
2.1  Findings
2.1.1  Descriptive Statistics, the Model Reliability 
and Validity
Table 1
Mean, Standard Deviation, Correlation, and Cronbach’s Alpha of the Construct
Construct Mean St. Dev. Human capital Structural capital Customercapital Alpha coefficient
Human cap. 3.49 0.93 0.78
Structural cap. 3.46 1.02 0.67 0.74
Customer cap. 3.85 0.84 0.56 0.52 0.72
New product development 3.79 1.03 0.39 0.44 0.54 0.63
2.1.2  Reliability
In table 1, Cronbach’s alpha of each variable is given. 
As is seen, alpha-value of new product development is 
smaller than 0.7, suggesting lack of reliability in this 
variable. However, there is still another and more accurate 
reliability measure proposed by Fornell and Larcker (1981) 
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termed composite reliability. The composite reliability 
for each variable is provided in table 2. The advantage 
of this method relative to Cronbach’s alpha lies in its use 
of real load factor (winze, et al., 2010). In this method, 
reliability threshold is set at 0.7. Composite reliability of 
new product development shown in table 2 is higher than 
0.7, which confirms reliability of this variable.
Table 2 
Validity and Reliability Values of Variables
Hidden variables Average variance extracted Composite reliability
Human cap.
Structural cap. 0.500 0.819
Customer cap. 0.551 0.830
New product 
development 0.555 0.783
2.1.3  Convergent Validity Versus Discriminate Validity
In test of the model by Smart PLS software, to see if 
subscales of each construct do measure what we expected 
from them or not, convergent and discriminate validity 
test is used (winze, et al., 2010). According to Fornell 
and Larcker (1981), if average variance extracted (AVE) 
becomes greater than 50%, there is convergent validity, 
the values of which are presented in table 2. However, 
if AVE of each variable be greater than correlation of 
the variable with other variables, there is discriminate 
validity (Fornell & Larcker, 1981). AVE square root 
of 3 variables structural capital, customer capital, and 
new product development is 0.707, 0.742, and 0.744, 
respectively, which is greater than the greatest correlation 
between these variables which are 0.650, 0.571, and 0.524, 
respectively. Thus, the research model has discriminate 
validity. The results on convergent and composite validity 
are provided in table 2.
As is seen in table 2, AVE of all three variables is either 
greater than or equal to the threshold of 0.5, implying 
the model fitness for the purpose of this research. The 
state of the research variables in the understudy firms is 
summarized in table 3.
2.1.4  Analysis of Structural Model
In PLS method, the structural model and its associated 
hypotheses is tested based on the calculated values of 
path coefficients (βs) and significance level (t-values), and 
the model goodness of fit is determined by R2 for each 
dependent variable.
Table 3
Mean, Standard Deviation, Loading, and T-Values for the Research Subscales




Company employee competence is at ideal level. 3.117 1.062 0.694 7.211
For employee training and keeping them up-to-
date, regular programs are prepared. 3.082 1.093 0.520 4.317
Employee learning and training has effect on 
company profitability. 4.305 0.724 0.726 8.580
Company employees are specialized in their 
professional areas. 3.423 1.004 0.690 6.904
C o m p a n y  e m p l o y e e s  c a r r y  o u t  t h e i r 
organizational tasks to the full. 3.376 0.987 0.574 4.488
Employees feel proud of company efficiency. 3.717 0.825 0.506 4.171
Employee work experience and specialization 
is has effect on company productivity and 
profitability.
4.305 0.707 0.627 5.544
Structural capital
Company selects and recruits the best and the 
most able applicants. 3.023 1.112 0.779 13.079
Company properly rewards employee good 
performance. 2.705 1.163 0.613 6.700
In company, employees have access to the 
Internet. 3.435 1.199 0.572 5.747
Company supports R&D unit and ensures it. 3.917 0.941 0.791 22.097
Company R&D affects its productivity and 
profitability. 4.070 0.910 0.749 14.901
To be continued
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Company maintains a long-term relationship with 
customers. 3.952 0.815 0.700 8.425
The market in which the company operates has 
growth potentials. 4.023 0.801 0.810 17.961
Company resolves customer problems in the least 
time. 3.388 1.012 0.691 9.940
Relat ionship of company with customers 
and suppliers of raw materials influences its 
productivity and profitability.





Act ivi t ies  of  R&D promote new product 
development. 3.776 1.050 0.862 21.649
Creative solutions and ideas of specialized 
employees promote new product development. 3.552 1.180 0.600 3.990
New product is an innovation and is not imitated. 3.247 1.290 0.649 5.542
Company  makes  e ffo r t  fo r  new produc t 
development. 4.247 0.738 0.508 3.811
Customers will positively react to new product 
launching.  4.141 0.927 0.505 3.411
Continued
2.1.5  Quality Evaluation of Structural Model
As was said earlier, this model contains a formative 
variable (human capital) which takes part in the formative 
model where all variance inflation factors (VIFs) ought 
to be smaller than 5, and in our study all of the VIFs are 
smaller than 5 (1.529 < VIF < 2.175). In addition, the 
obtained R2 for three variables structural, customer, and 
new product development is 0.421, 0.329, and 0.348, 
respectively, all of which are higher than the threshold of 
0.19. Considering R2-value for endogenous constructs, it 
can be inferred that the model properly fits the data. The 
effect power (Quality of the structural model) is calculated 
based on f2-statistic. Analysis of this measure serves as 
complementary to R2-statistic in that it determines effect 
power of a hidden (latent) independent variable on a 
hidden (latent) dependent variable (Chin, 2010). The 
f2-statistics (effect power factor) 0.02, 0.15, and 0.35 
indicate a low, medium, and high effect size, respectively 
in analysis and prediction of variables (winze, 2010).
Table 4 
Effect Power Factor (f2) and the Structural Model 
Evaluation
Constructs Effect power factor (f2) Effect size
Human capital 0.201 Medium
Structural capital 0.195 Medium
Customer capital 0.157 Medium
New product development 0.186 Medium
2.1.6  Test of Hypotheses
For test of hypotheses, significance of the path 
coefficients is put to test in the model. For this purpose, 
it is made use of self-adaptive method as it gives a more 
reasonable and more concrete standard error (Tenenhaus, 
et al., 2005). In this method, test result is expressed in two 
statistics: β and t-value. An absolute t-value higher than 
1, 96 indicates path significance. Path coefficients of the 
research model are provided in Table 5 and the model path 
analysis is given in Figure 2.
Table 5 
Model Path Coefficients
Path β T-value (Bootstrapping)
Human capital  Structural cap.   0.649 8.685
**
Human capital  Customer cap.   0.574 7.158
**
Human capital  New product dev. - 0.009 0.052
Structural cap.  New product dev.   0.277 2.407
*
Customer cap.  New product dev.   0.409 3.311
**
* Significant at 0.05 (two-tailed)    ** Significant at 0.001 (two-tailed)
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CONCLUSION AND SUGGESTIONS
The findings in this study suggest positive and significant 
effect of human capital on structural capital (β = 0.649, p 
< 0.001) and therefore hypothesis 1 is confirmed. Human 
capital is also found to be positively and significantly 
correlated to customer capital (β = 0.574, p < 0.001) and 
thereby the second hypothesis is validated and confirmed. 
However, our results do not indicate any association, let 
alone a significant association, between human capital and 
new product development (β = -0.009), hence hypothesis 
3 cannot be confirmed. As regards structural capital, 
the results indicate a positive and relatively significant 
association between structural capital and new product 
development (β = 0.277, p < 0.05) and hypothesis 4 is 
confirmed. And finally, is the positive and significant 
effect of customer capital on new product development (β 
= 0.409, p < 0.001) which clearly justifies confirmation of 
hypothesis 5.
As the results of data analysis suggested, human 
capital in pharmaceutical companies of Isfahan province 
had no effect on new product development. This result 
is very remarkable, because according to the theory of 
intellectual capital, human capital as the most critical 
element plays a pivotal role. It is argued that in presence 
of a poor human capital, other organizational capitals 
are rendered ineffective and inefficient. Therefore, 
the pharmaceutical companies require focusing on 
development of their human capital if they truly wish 
to improve their new product development process. For 
promotion and development of human capital, in the first 
place, hones and strongly committed employees should 
be recruited, and subsequently the necessary investment 
(and reinvestment) should be made for promotion 
and enrichment of their professional knowledge and 
expertise on a continuous basis (Pasher & Ronen, 2011). 
The 1st and 2nd items of the subscale human capital 
which measure employee competence and training with 
standard deviation of 1.06 and 1.093, respectively, score 
higher than rest of the items in this category, signifying 
a considerable gap from the desirable state of task 
assignment in appointing right people to various jobs 
and positions, while continuously updating employee 
knowledge. In addition, the mean score (2.705) and 
standard deviation (1.163) of item 9in the questionnaire, 
evidently is suggestive of a disproportionate reward 
system, in the sense that employees do not receive the 
right reward for their good performance. And this has 
presumably undermined the impact of structural capital 
on new product development (β = 0.277) which relative 
to other variables, after human capital, shows the least 
effect on new product development. Therefore, to 
boost new product development, a shift in the current 
practice of managers in these firms towards a more 
effective employee reward system and better alignment 
of performance and reward is highly recommendable. 
Further, the responses to items 8 and 10 which concern 
possibility of Internet use in workplace and recruitment of 
best job applicants in the understudy firms with the highest 
measure of variability (1.199 and 1.112, respectively) on 
the one hand, refer to importance of Internet access for all 
the involved employees in the production process, and on 
the other hand, calls for adoption of more comprehensive 
recruitment procedures. In regard to item 15, resolving 
customer problems by the company in the shortest time, 
with a smaller mean (3.388) and greater standard deviation 
(1.012) relative to other items in the subscale customer 
capital, establishment of a stronger and more interactive 
relationship with customers, company employees, and 
business partners who themselves in a broader sense 
are regarded a customer to the company, as well as with 
knowledge production networks such as universities and 
research centers enable the company to learn from them 
and profit from their ideas on new product development. 
As for the subscale new product development,  the 
responses to items 18 and 19 indicate that in these 
companies employees’ ideas and creative solutions are not 
adequately made use of in new product development, and 
that the so called new product is rather an imitation than 
an innovation. One way to allow effective contribution 
of the employee ideas in new product development 
is interdepartmental collaboration. At any rate, these 
companies, in order to survive the competition and 
get competitive advantage over rivals, would need to 
transform their companies into learning organizations 
and upgrade their employees to knowledge workers, and 
would inevitably have to enter into active interaction 
and knowledge sharing arrangements with research and 
academic centers, as well as with other competitors. 
The interpretative ability of intellectual capital is also 
noteworthy. R2for the model on the whole equals 0.348 
which implies that intellectual capital accounts for 34.8 
percent contribution to new product development in 
pharmaceutical companies. Future research in this area 
may further probe the causes of the missing human 
capital in the process of new product development in the 
understudy firms, since an elaboration on this issue would 
be insightful for managers of these companies and would 
greatly help approaching and resolving this issue. As 
the last point in this regard, it should be noted that given 
the broad sense of the concept intellectual capital which 
assumes a large variety of implications for almost every 
facet of the organization (including human resources, 
structure and organization, stakeholders and customers, 
and suppliers of raw materials), use of more extensive 
subscales comprising all these aspects can be instrumental 
to future problem solving attempts.
REFERENCES
Alegre, J., & Chiva, R. (2008). Assessing the impact of 
Assessing the Effect of Intellectual Capital on New Product 
Development (Case Study: Pharmaceutical Industry of Isfahan 
Province)
212Copyright © Canadian Research & Development Center of Sciences and Cultures
organizational learning capability on product innovation 
performance: An empirical test. Journal of management, 
28, 315-326.
Bollen, L., Vergauwen, P., & Schnieders, S. (2005). Linking 
intellectual capital and intellectual property to company 
performance. Management Decision, 43(9), 1161-1185.
Bontis, N. (1998). Intellectual capital: An exploratory study that 
develops measures and models. Management Decision, 
36(2), 63-76.
Bontis, N. (2004). National intellectual capital index, a 
United Nations initiative for the Arab region. Journal of 
Intellectual Capital, 1, 13-39.
Bontis, N., Keow, W. C. C. & Richardson, S. (2000). Intellectual 
capital and business performance in Malaysian industries. 
Journal of Intellectual Capital, 1(1), 85-100.
Bounfour, A., & Edvinsson, L. (2005). Intellectual capital for 
communities: nations, regions, and cities. Burlington 
Elsevier Butterworth–Heinemann.
Chen, H. M., & Lin, K. J. (2004). The role of human capital cost 
in accounting. Journal of Intellectual Capital, 5, 116-130.
Chen, Y-S., James Lin, M-J., & Chang, C-H. (2006). The 
influence of intel lectual  capital  on new product 
development performance - The manufacturing companies 
of Taiwan as an example. Total Quality Management & 
Business Excellence, 17, 1323-1339.
Chin, W. W. (1998). The partial least squares approach for 
structural modeling. Journal of Intellectual Capital, 9(4), 
609-638.
Chin, W. W. (2010). How to write up and report PLS analyses. 
In Vinci, V., et al. (Eds.), Handbook of partial least 
squares: Concepts, methods and applications (pp. 655-
690). Heidelberg, Springer.
Chong, K. K. (2008). Intellectual capital: Definitions, 
categorization and reporting models. Journal of Intellectual 
Capital, 9(4), 609-638.
Chou, C. W., & Bontis, N. (2002). The strategic management 
of intellectual capital and organizational knowledge. New 
York: Oxford University Press.
Collis, D. J. (1996). Organizational capability as a source 
of profit. In Moingeon, B. &  Edmondson, A. (Eds.), 
Organizational learning and competitive advantage. 
London: Sage.
Cooper, R. G., & Kleinschmidt, E. J. (1996). Winning business 
in product development: The critical success factors, Res. 
Technol. Manag., 39(4), 18-29.
De Jong, J. P. J., & Den Hartog, D. N. (2007). How leaders 
inﬂuence employees’ innovative behavior. European 
Journal of Innovation Management, 10(1), 41-64.
Edvinsson, L., & Sullivan, P. (1996). Developing a model for 
managing intellectual capital. Eur. Manag. J., 14(4) 356-364.
Engstro¨, T. E. J., Westnes, P., & Westnes, S. F. (2003). 
Evaluating intellectual capital in the hotel industry. Journal 
of Intellectual Capital, 4(3), 287-303.
Esposito V., & Chin, W. W., Henseler, J., & Wang, H. (2010). 
Handbook of partial least squares, concepts, methods and 
applications. Heidelberg, Springer.
Fang, W., & Hsu, Y. (2009). Intellectual capital and new 
product development performance: The mediating role 
of organizational learning capability. Technological 
Forecasting & Social Change, 76, 664-677.
Fornell, C., & Larcker, D. F. (1981). Evaluating structural equations 
models with unobservable variables and measurement error. 
Journal of Marketing Research, 18, 39-50.
Garcia-Meca, E. (2006). Bridging the gap between disclosure 
and use of intellectual capital information. Journal of 
Intellectual Capital, 6(3), 427-440.
Goal, Ed. (2001). Modern Methods for Business Research (pp. 
295-336). Mahwah, NJ: Lawrence Erlbaum Associates.
Griffin,  A.  (1997).  Modeling and measuring product 
development cycle time across industries. J. Eng. Technol. 
Manag., 14(1), 1-24.
Hair, J. F., Sarstedt, M., Ringle, C. M., & Mena, J. A. (2012). 
An assessment of the use of partial least squares structural 
equation modeling in marketing research. Journal of the 
Academy of Marketing Science, 40, 414-433.
Hancock, P. H., Pew Tan, H., & Plowman, D. (2008). The 
evolving research on intellectual capital. Journal of 
Intellectual Capital, 9(4), 585-608.
Hulland, J. (1999). Use of Partial Least Squares (PLS) in 
strategic management research: A review of four recent 
studies. Strategic Management Journal, 20, 195-204.
Lin, C. Y. Y., & Edvinsson, L. (2011). National intellectual 
capital: A comparison of 40 countries. New York, NY: 
Springer.
Marr, B. (2005). Perspectives on intellectual capital. Burlington, 
Elsevier Butterworth-Heinemann, 7(3), 382-397.
Martinez-Torres, M. R. (2006). A procedure to design a 
structural and measurement model of intellectual capital: 
An exploratory study. Information & Management, 43, 
617-626.
Mehralian, G. H., Rasekh, H. R., Akhavan, P., & Sadeh, 
M. R. (2012).  The impact of intellectual  capital 
efficiency on market value: An empirical study from 
Iranian pharmaceutical companies. Iranian Journal of 
Pharmaceutical Research, 11(1), 195-207.
Namasivayam, K., & Denizci, B. (2006). Human capital in 
service organizations: Identifying value drivers. Journal of 
Intellectual Capital, 7(3), 381-393.
Nonaka, I., & Takeuchi, H. (1995). The knowledge creating 
company. New York: Oxford University Press.
Ordonez de Pablo’s, P. (2005). Intellectual capital reports in 
India: Lessons from a case study. Journal of Intellectual 
Capital, 6, 141-149.
Pasher, E., & Ronen, T. (2011). The complete guide to knowledge 
management: A strategic plan to leverage your company’s 
intellectual capital. New Jersey: John Wiley & Sons, Inc., 
Hoboken.
Rastogi, P. N. (2003). The nature and role of IC – rethinking the 
process of value creation and sustained enterprise growth. 
Journal of Intellectual Capital, 4(2), 227-248.
Nabiallah Kohan; Mojtaba Rafie; Seyed-Hasan Hosseini (2014). 
International Business and Management, 8(2), 206-213
213 Copyright © Canadian Research & Development Center of Sciences and Cultures
Ringle, C. M., Wende, S., & Will, A. (2005). Smart PLS, 2.0. 
Hamburg, Germany.
Rose Luo, X., Koput, K. W., & Powell, W. W. (2009). 
Intellectual capital or signal: The effects of scientists on 
alliance formation in knowledge-intensive industries. 
Research Policy, 38, 1313-1325.
Serenko, A., Bontis, N., & Booker, L. D. (2007). The mediating 
effect of organizational reputation on customer loyalty 
and service recommendation in the banking industry. 
Management Decision, 45, 1426-1445.
Sharabati, J., Bontis, L., & NajiJawad, Sh. (2010). Intellectual 
capital and business performance in the pharmaceutical 
sector of Jordan. Management Decision, 48, 105-131.
Stewart, T. A. (1997). Intellectual capital: The wealth of new 
organizations. London, Nicholas Bradley Publishing Ltd.
Tenenhaus, M., Esposito Vinzi, V., Chatelin, Y. M., & Lauro, C. 
(2005). PLS path modeling. Computational Statistics & 
Data Analysis, 48, 159-205.
Wang, W. Y., & Chang, C. (2005). Intellectual capital and 
performance in causal models: Evidence from the 
information technology industry in Taiwan. Journal of 
Intellectual Capital, 6(2), 222-236.
Zucker, L. G., Darby, M. R. & Brewer, M. B. (1994). Intellectual 
capital and the birth of US biotechnology enterprise. 
Working Paper Series 4653, NBER, Cambridge.
